NBD-11021

a CD4 antagonist; structure in first source

Also Known As:

5-(4-chlorophenyl)-N-((5-(hydroxymethyl)-4-methylthiazol-2-yl)(piperidin-2-yl)methyl)-1H-pyrrole-2-carboxamide; NBD-11021A; NBD-11021B

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Infections 01/01/2017 - "In our attempt to optimize the lead HIV-1 entry antagonist, NBD-11021, we present in this study the rational design and synthesis of 60 new analogues and determination of their antiviral activity in a single-cycle and a multicycle infection assay to derive a comprehensive structure-activity relationship (SAR). "

1.	Antiviral Agents (Antivirals)